{"count": 29, "results": [{"_id": "37667332", "pmid": 37667332, "pmcid": "PMC10478412", "title": "Establishment of a large-scale patient-derived high-risk colorectal adenoma organoid biobank for high-throughput and high-content drug screening", "journal": "BMC Med", "authors": ["Luo Z", "Wang B", "Luo F", "Guo Y", "Jiang N", "Wei J", "Wang X", "Tseng Y", "Chen J", "Zhao B", "Liu J"], "date": "2023-09-04T00:00:00Z", "doi": "10.1186/s12916-023-03034-y", "meta_date_publication": "2023 Sep 4", "meta_volume": "21", "meta_issue": "1", "meta_pages": "336", "score": 50282.438, "text_hl": "There are also other potential drugs for @<m>DISEASE_Adenoma</m> @DISEASE_MESH:D000236 @@@adenoma@@@ intervention including @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Luo Z, Wang B, Luo F, Guo Y, Jiang N, Wei J, Wang X, Tseng Y, Chen J, Zhao B, Liu J. Establishment of a large-scale patient-derived high-risk colorectal adenoma organoid biobank for high-throughput and high-content drug screening BMC Med. 2023 Sep 4;21(1):336. PMID: 37667332", "BibTeX": "@article{37667332, title={Establishment of a large-scale patient-derived high-risk colorectal adenoma organoid biobank for high-throughput and high-content drug screening}, author={Luo Z and Wang B and Luo F and Guo Y and Jiang N and Wei J and Wang X and Tseng Y and Chen J and Zhao B and Liu J}, journal={BMC Med}, volume={21}, number={1}, pages={336}}"}}, {"_id": "35022906", "pmid": 35022906, "title": "Metformin Use Is Inversely Associated with Prevalent, but Not Incident Colorectal Adenomas.", "journal": "Dig Dis Sci", "authors": ["Krigel A", "Nguyen STT", "Talukder N", "Huang CH", "Buitrago C", "Karkenny G", "Lebwohl B", "Abrams JA", "Araujo JL"], "date": "2022-10-01T00:00:00Z", "doi": "10.1007/s10620-021-07336-0", "meta_date_publication": "2022 Oct", "meta_volume": "67", "meta_issue": "10", "meta_pages": "4886-4894", "score": 50274.26, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Use Is Inversely Associated with Prevalent, but Not Incident @<m>DISEASE_Adenoma</m> @DISEASE_MESH:D000236 @@@Colorectal Adenomas@@@.", "citations": {"NLM": "Krigel A, Nguyen STT, Talukder N, Huang CH, Buitrago C, Karkenny G, Lebwohl B, Abrams JA, Araujo JL. Metformin Use Is Inversely Associated with Prevalent, but Not Incident Colorectal Adenomas. Dig Dis Sci. 2022 Oct;67(10):4886-4894. PMID: 35022906", "BibTeX": "@article{35022906, title={Metformin Use Is Inversely Associated with Prevalent, but Not Incident Colorectal Adenomas.}, author={Krigel A and Nguyen STT and Talukder N and Huang CH and Buitrago C and Karkenny G and Lebwohl B and Abrams JA and Araujo JL}, journal={Dig Dis Sci}, volume={67}, number={10}, pages={4886-4894}}"}}, {"_id": "31818523", "pmid": 31818523, "title": "Suppressive effects of metformin on colorectal adenoma incidence and malignant progression.", "journal": "Pathol Res Pract", "authors": ["Deng M", "Lei S", "Huang D", "Wang H", "Xia S", "Xu E", "Wu Y", "Zhang H"], "date": "2020-02-01T00:00:00Z", "doi": "10.1016/j.prp.2019.152775", "meta_date_publication": "2020 Feb", "meta_volume": "216", "meta_issue": "2", "meta_pages": "152775", "score": 50274.062, "text_hl": "Suppressive effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Adenoma</m> @DISEASE_MESH:D000236 @@@colorectal adenoma@@@ incidence and malignant progression.", "citations": {"NLM": "Deng M, Lei S, Huang D, Wang H, Xia S, Xu E, Wu Y, Zhang H. Suppressive effects of metformin on colorectal adenoma incidence and malignant progression. Pathol Res Pract. 2020 Feb;216(2):152775. PMID: 31818523", "BibTeX": "@article{31818523, title={Suppressive effects of metformin on colorectal adenoma incidence and malignant progression.}, author={Deng M and Lei S and Huang D and Wang H and Xia S and Xu E and Wu Y and Zhang H}, journal={Pathol Res Pract}, volume={216}, number={2}, pages={152775}}"}}, {"_id": "36688306", "pmid": 36688306, "title": "Metabolic and Metabolomic Effects of Metformin in Murine Model of Pulmonary Adenoma Formation.", "journal": "Nutr Cancer", "authors": ["Elton AC", "Cedarstrom V", "Quraishi A", "Wuertz B", "Murray K", "Markowski TW", "Seabloom D", "Ondrey FG"], "date": "2023-01-01T00:00:00Z", "doi": "10.1080/01635581.2023.2165692", "meta_date_publication": "2023", "meta_volume": "75", "meta_issue": "3", "meta_pages": "1014-1027", "score": 50269.414, "text_hl": "Metabolic and Metabolomic Effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @SPECIES_10090 @@@Murine@@@ Model of @<m>DISEASE_Adenoma</m> @DISEASE_MESH:D000236 @@@Pulmonary Adenoma@@@ Formation.", "citations": {"NLM": "Elton AC, Cedarstrom V, Quraishi A, Wuertz B, Murray K, Markowski TW, Seabloom D, Ondrey FG. Metabolic and Metabolomic Effects of Metformin in Murine Model of Pulmonary Adenoma Formation. Nutr Cancer. 2023;75(3):1014-1027. PMID: 36688306", "BibTeX": "@article{36688306, title={Metabolic and Metabolomic Effects of Metformin in Murine Model of Pulmonary Adenoma Formation.}, author={Elton AC and Cedarstrom V and Quraishi A and Wuertz B and Murray K and Markowski TW and Seabloom D and Ondrey FG}, journal={Nutr Cancer}, volume={75}, number={3}, pages={1014-1027}}"}}, {"_id": "33838541", "pmid": 33838541, "pmcid": "PMC8058559", "title": "Narrative review of the influence of diabetes mellitus and hyperglycemia on colorectal cancer risk and oncological outcomes", "journal": "Transl Oncol", "authors": ["Cheng HC", "Chang TK", "Su WC", "Tsai HL", "Wang JY"], "date": "2021-07-01T00:00:00Z", "doi": "10.1016/j.tranon.2021.101089", "meta_date_publication": "2021 Jul", "meta_volume": "14", "meta_issue": "7", "meta_pages": "101089", "score": 50261.426, "text_hl": "Dysregulation of the @GENE_PRKAB1 @GENE_5564 @@@AMP-activated protein kinase@@@ (@GENE_PRKAB1 @GENE_5564 @@@AMPK@@@) pathway leads to metabolic imbalance and indicates @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ risk. The use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ for chemoprevention has been shown to reduce @DISEASE_Colorectal_Neoplasms @DISEASE_MESH:D015179 @@@CRC@@@ and @<m>DISEASE_Adenoma</m> @DISEASE_MESH:D000236 @@@adenoma@@@ incidence through the upregulation of @GENE_PRKAB1 @GENE_5564 @@@AMPK@@@, which causes cell cycle arrest in the Gap 1-S (G1-S) phase and inhibits the @GENE_MTOR @GENE_2475 @@@mTOR@@@ pathway, even potentially reversing the epithelial-mesenchymal transition. ", "citations": {"NLM": "Cheng HC, Chang TK, Su WC, Tsai HL, Wang JY. Narrative review of the influence of diabetes mellitus and hyperglycemia on colorectal cancer risk and oncological outcomes Transl Oncol. 2021 Jul;14(7):101089. PMID: 33838541", "BibTeX": "@article{33838541, title={Narrative review of the influence of diabetes mellitus and hyperglycemia on colorectal cancer risk and oncological outcomes}, author={Cheng HC and Chang TK and Su WC and Tsai HL and Wang JY}, journal={Transl Oncol}, volume={14}, number={7}, pages={101089}}"}}, {"_id": "37987968", "pmid": 37987968, "title": "Is Metformin Associated with a Lower Prevalence of Polyps, Adenomas, and Colorectal Carcinoma in Patients with Diabetes Mellitus?", "journal": "J Gastrointest Cancer", "authors": ["Canha MI", "Ramos G", "Prata R", "Lages Martins P", "Viúla Ramos M", "Coimbra J"], "date": "2023-11-21T00:00:00Z", "doi": "10.1007/s12029-023-00989-2", "meta_date_publication": "2023 Nov 21", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50257.836, "text_hl": "Is @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Associated with a Lower Prevalence of @DISEASE_Polyps @DISEASE_MESH:D011127 @@@Polyps@@@, @<m>DISEASE_Adenoma</m> @DISEASE_MESH:D000236 @@@Adenomas@@@, and @DISEASE_Colorectal_Neoplasms @DISEASE_MESH:D015179 @@@Colorectal Carcinoma@@@ in Patients with @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetes Mellitus@@@?", "citations": {"NLM": "Canha MI, Ramos G, Prata R, Lages Martins P, Viúla Ramos M, Coimbra J. Is Metformin Associated with a Lower Prevalence of Polyps, Adenomas, and Colorectal Carcinoma in Patients with Diabetes Mellitus? J Gastrointest Cancer. 2023 Nov 21;():. PMID: 37987968", "BibTeX": "@article{37987968, title={Is Metformin Associated with a Lower Prevalence of Polyps, Adenomas, and Colorectal Carcinoma in Patients with Diabetes Mellitus?}, author={Canha MI and Ramos G and Prata R and Lages Martins P and Viúla Ramos M and Coimbra J}, journal={J Gastrointest Cancer}}"}}, {"_id": "40353629", "pmid": 40353629, "title": "Metformin for recurrent colorectal polyp or adenoma prevention after polypectomy in patients without diabetes mellitus: a prospective study.", "journal": "Neoplasma", "authors": ["Wang W", "Luo B", "Wang Z", "Zhang J", "Ye Z", "He X", "Li D", "Sun D"], "date": "2025-04-01T00:00:00Z", "doi": "10.4149/neo_2025_250319N130", "meta_date_publication": "2025 Apr", "meta_volume": "72", "meta_issue": "1-2", "meta_pages": "", "score": 50257.023, "text_hl": "For the number of recurrent @<m>DISEASE_Adenoma</m> @DISEASE_MESH:D000236 @@@adenomas@@@ per subject, the difference between the control and the high-dose @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ groups was significant (0.86+-1.09 vs. 0.47+-0.83, p=0.020). ", "citations": {"NLM": "Wang W, Luo B, Wang Z, Zhang J, Ye Z, He X, Li D, Sun D. Metformin for recurrent colorectal polyp or adenoma prevention after polypectomy in patients without diabetes mellitus: a prospective study. Neoplasma. 2025 Apr;72(1-2):. PMID: 40353629", "BibTeX": "@article{40353629, title={Metformin for recurrent colorectal polyp or adenoma prevention after polypectomy in patients without diabetes mellitus: a prospective study.}, author={Wang W and Luo B and Wang Z and Zhang J and Ye Z and He X and Li D and Sun D}, journal={Neoplasma}, volume={72}, number={1-2}}"}}, {"_id": "32592092", "pmid": 32592092, "title": "Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression.", "journal": "Int J Colorectal Dis", "authors": ["Ng CW", "Jiang AA", "Toh EMS", "Ng CH", "Ong ZH", "Peng S", "Tham HY", "Sundar R", "Chong CS", "Khoo CM"], "date": "2020-08-01T00:00:00Z", "doi": "10.1007/s00384-020-03676-x", "meta_date_publication": "2020 Aug", "meta_volume": "35", "meta_issue": "8", "meta_pages": "1501-1512", "score": 50253.98, "text_hl": "RESULTS: We included 58 studies and summarized incidences of @DISEASE_Colorectal_Neoplasms @DISEASE_MESH:D015179 @@@colorectal adenoma and cancer@@@, as well as @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ survival outcomes. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ users had a significant lower incidence of @<m>DISEASE_Adenoma</m> @DISEASE_MESH:D000236 @@@colorectal adenoma@@@ (RR 0.77, CI 0.67-0.88, p < 0.001), advanced @<m>DISEASE_Adenoma</m> @DISEASE_MESH:D000236 @@@adenoma@@@ (0.61, CI 0.42-0.88, p = 0.008) and @DISEASE_Colorectal_Neoplasms @DISEASE_MESH:D015179 @@@CRC@@@ (RR 0.76, CI 0.69-0.84, p < 0.001) respectively compared with non-@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ users. ", "citations": {"NLM": "Ng CW, Jiang AA, Toh EMS, Ng CH, Ong ZH, Peng S, Tham HY, Sundar R, Chong CS, Khoo CM. Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression. Int J Colorectal Dis. 2020 Aug;35(8):1501-1512. PMID: 32592092", "BibTeX": "@article{32592092, title={Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression.}, author={Ng CW and Jiang AA and Toh EMS and Ng CH and Ong ZH and Peng S and Tham HY and Sundar R and Chong CS and Khoo CM}, journal={Int J Colorectal Dis}, volume={35}, number={8}, pages={1501-1512}}"}}, {"_id": "35878711", "pmid": 35878711, "title": "The efficacy of chemopreventive agents on the incidence of colorectal adenomas: A systematic review and network meta-analysis.", "journal": "Prev Med", "authors": ["Heer E", "Ruan Y", "Mah B", "Nguyen T", "Lyons H", "Poirier A", "Boyne DJ", "O'Sullivan DE", "Heitman SJ", "Hilsden RJ", "Forbes N", "Brenner DR"], "date": "2022-09-01T00:00:00Z", "doi": "10.1016/j.ypmed.2022.107169", "meta_date_publication": "2022 Sep", "meta_volume": "162", "meta_issue": "", "meta_pages": "107169", "score": 50252.79, "text_hl": "Of 20,925 included @SPECIES_9606 @@@patients@@@, 7766 had an @<m>DISEASE_Adenoma</m> @DISEASE_MESH:D000236 @@@adenoma@@@. Compared to placebo, the combination of @CHEMICAL_Eflornithine @CHEMICAL_MESH:D000518 @@@difluoromethylornithine@@@ (@CHEMICAL_Eflornithine @CHEMICAL_MESH:D000518 @@@DFMO@@@) + @CHEMICAL_Sulindac @CHEMICAL_MESH:D013467 @@@Sulindac@@@ (RR 0.24, CrI 0.10-0.55) demonstrated a protective effect, while @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@aspirin@@@ had a RR of 0.77 (CrI 0.60-1.00), @CHEMICAL_Celecoxib @CHEMICAL_MESH:D000068579 @@@celecoxib@@@ 800 mg had a RR of 0.56 (CrI 0.31-1.01) and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ had a RR of 0.56 (CrI 0.22-1.39). ", "citations": {"NLM": "Heer E, Ruan Y, Mah B, Nguyen T, Lyons H, Poirier A, Boyne DJ, O'Sullivan DE, Heitman SJ, Hilsden RJ, Forbes N, Brenner DR. The efficacy of chemopreventive agents on the incidence of colorectal adenomas: A systematic review and network meta-analysis. Prev Med. 2022 Sep;162():107169. PMID: 35878711", "BibTeX": "@article{35878711, title={The efficacy of chemopreventive agents on the incidence of colorectal adenomas: A systematic review and network meta-analysis.}, author={Heer E and Ruan Y and Mah B and Nguyen T and Lyons H and Poirier A and Boyne DJ and O'Sullivan DE and Heitman SJ and Hilsden RJ and Forbes N and Brenner DR}, journal={Prev Med}, volume={162}, pages={107169}}"}}, {"_id": "34749618", "pmid": 34749618, "title": "The Emerging Role of Metformin in the Prevention and Treatment of Colorectal Cancer: A Game Changer for the Management of Colorectal Cancer.", "journal": "Curr Diabetes Rev", "authors": ["Ala M"], "date": "2022-01-01T00:00:00Z", "doi": "10.2174/1573399818666211105125129", "meta_date_publication": "2022", "meta_volume": "18", "meta_issue": "8", "meta_pages": "e051121197762", "score": 50251.5, "text_hl": "Furthermore, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ decreases the risk of new @DISEASE_Polyps @DISEASE_MESH:D011127 @@@polyps@@@ and @<m>DISEASE_Adenoma</m> @DISEASE_MESH:D000236 @@@adenomas@@@ in @SPECIES_9606 @@@patients@@@ without @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@. ", "citations": {"NLM": "Ala M. The Emerging Role of Metformin in the Prevention and Treatment of Colorectal Cancer: A Game Changer for the Management of Colorectal Cancer. Curr Diabetes Rev. 2022;18(8):e051121197762. PMID: 34749618", "BibTeX": "@article{34749618, title={The Emerging Role of Metformin in the Prevention and Treatment of Colorectal Cancer: A Game Changer for the Management of Colorectal Cancer.}, author={Ala M}, journal={Curr Diabetes Rev}, volume={18}, number={8}, pages={e051121197762}}"}}]}